Cresco Labs Launches Flagship Flower Brand in Germany

Executive Summary

• Cresco Labs announced the commercial launch of its branded cannabis flower in Germany, marking the company’s first entry into the European Union market.
• The rollout includes three signature flower products manufactured by EU‑GMP partner Blossom in Portugal and sold via prescription through licensed German pharmacies.
• The expansion is positioned as a pilot to gather regulatory and market insights that will guide future growth decisions across Europe.

Key Details

• Geographic Expansion: First EU commercial entry – product now available in Germany.
• Product Offering: Three signature flower products, each targeted to specific patient effects.
• Manufacturing Partner: Blossom (EU‑GMP certified facility in Portugal).
• Distribution Channel: Prescription sales through licensed pharmacies across Germany.
• Strategic Rationale: Leverage Cresco’s brand portfolio and operational expertise to capture growth in one of the world’s fastest‑growing regulated cannabis markets.
• CEO Quote: “After extensive work understanding the European landscape, we’re confident that Cresco can deliver meaningful value… Our objective is to use these insights to guide future growth decisions in evolving markets.” – Charlie Bachtell, CEO.

Notable Quotes

“Our objective is to use these insights to guide future growth decisions in evolving markets.” – Charlie Bachtell, CEO, Cresco Labs.